Patent ID: 7919240

Claim:
A method to evaluate a patient, the method comprising subjecting a tissue sample from a human patient with asthma to gene analysis, the analysis resulting in an expression profile of at least one gene activated in lungs of a human patient with asthma, comparing the patient's gene expression profile with a gene expression profile for stable asthma and a gene expression profile for exacerbated asthma, and determining whether the patient has a propensity for at least one of stable asthma or exacerbated asthma based on at least a two-fold difference between at least one gene in the patient's gene expression profile and the stable asthma or exacerbated asthma expression profile, wherein the patient has a propensity for stable asthma when the at least two-fold difference is between the patient's gene expression profile and the gene expression profile for exacerbated asthma, or the patient has a propensity for exacerbated asthma when the at least two-fold difference is between the patient's gene expression profile and the gene expression profile for stable asthma.